コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 L/min/%, p < 0.05] with acute restoration to normocapnia).
2 her contribution from RAP in comparison with normocapnia.
3 al mortality than compensated hypercapnia or normocapnia.
4 c breathing, hypocapnia, and after return to normocapnia.
5 epithelial injury and cell death compared to normocapnia.
6 nclusion of the study, a total of 90 mins of normocapnia.
7 going hypercapnia for 6 hrs with a return to normocapnia.
8 change during hypercapnia or with return to normocapnia.
9 was returned to the baseline value, that is, normocapnia.
10 97% total CO2 production) while maintaining normocapnia.
11 duced the respiratory rate while maintaining normocapnia.
12 arteriovenous CO2 removal while maintaining normocapnia.
13 argeted mild hypercapnia and 853 to targeted normocapnia.
14 eurologic outcomes at 6 months than targeted normocapnia.
15 ting reductions of 5 and 10 mmHg compared to normocapnia.
16 ificant decrease in respiratory rate (RR) at normocapnia, an elevated RR during hypoxia, and an atten
17 entilating the piglets with 100% O(2) during normocapnia and concomitantly topically applying artific
22 combination of pH and carbon dioxide levels (normocapnia and normal pH, compensated hypercapnia [norm
24 roup, arterial blood pH was 7.42 +/- 0.02 at normocapnia and was maintained at 7.37 +/- 0.01 while Pa
25 graphy) were performed during 5 min at rest (normocapnia) and during four breathing manoeuvres: 5% an
26 rate (ECG) were performed for 5 min at rest (normocapnia) and during hypercapnia induced by breathing
28 at normocapnia to 7.14 +/- 0.01 (p < .01 vs. normocapnia) as blood PCO2 increased to 81.2 +/- 1.8 tor
29 V(T) = 8 mL/kg, respiratory rate adjusted to normocapnia) at low (n = 2, positive end-expiratory pres
32 omy, Sprague-Dawley rats were randomized to (normocapnia; FICO2 0.00) or (hypercapnic acidosis; FICO2
34 apnia group and in 350 of 784 (44.6%) in the normocapnia group (relative risk, 0.98; 95% confidence i
35 apnia group and in 382 of 832 (45.9%) in the normocapnia group (relative risk, 1.05; 95% CI, 0.94 to
38 ous arterial spin labeling to measure CBF at normocapnia (ie, breathing room air) and hypercapnia.
40 repair was measured in AEC type 1 exposed to normocapnia (NC, 40 Torr) or HC (80 Torr), +/- trometham
41 went 4 hours of mechanical ventilation under normocapnia or hypercapnic acidosis, and nuclear factor-
42 ade a highly significant contribution during normocapnia (P < 0.0001) and was the sole determinant of
43 ng injury under the following conditions: a) normocapnia (Paco2 35 to 45 torr [4.7 to 6.0 kPa]) and n
45 rr) in normoxic (pO2 approximately 100 Torr) normocapnia (pCO2 approximately 30 Torr, pH approximatel
46 on to ameliorate hypoventilation and restore normocapnia regardless of the cause of respiratory dysfu
47 o baseline of CBF and cerebral metabolism at normocapnia seen in our study with lambs may explain why
51 When preceded by nitrous oxide, midazolam or normocapnia, the risk of inducing epileptiform activity
52 ial blood pH decreased from 7.41 +/- 0.03 at normocapnia to 7.14 +/- 0.01 (p < .01 vs. normocapnia) a
54 the autoregulation index from 5.70 +/- 1.58 (normocapnia) to 4.14 +/- 2.05 (hypercapnia; P < 0.0001).
55 e pH-uncorrected group (9.0 +/- 1.5 mm Hg at normocapnia vs. 26.8 +/- 5.1 at 1 hr, p < .05), and rema
56 p < .05]; pH-corrected group: 4.1 +/- 0.4 at normocapnia vs. 5.7 +/- 0.4 L/min at 1 hr [p < .05]).
57 (pH-uncorrected group: 4.3 +/- 0.6 L/min at normocapnia vs. 6.8 +/- 1.0 L/min at 1 hr [p < .05]; pH-